Pseudomonas aeruginosa in chronic obstructive pulmonary disease.
about
Lung microbiology and exacerbations in COPDCrystal structure of the cystic fibrosis transmembrane conductance regulator inhibitory factor Cif reveals novel active-site features of an epoxide hydrolase virulence factorPseudomonas infection in chronic obstructive pulmonary diseaseCationic antimicrobial peptides promote microbial mutagenesis and pathoadaptation in chronic infectionsLung microbiome for clinicians. New discoveries about bugs in healthy and diseased lungs.Treatment of patients with COPD and recurrent exacerbations: the role of infection and inflammationCigarette smoke decreases airway epithelial FABP5 expression and promotes Pseudomonas aeruginosa infectionSecond-hand cigarette smoke impairs bacterial phagocytosis in macrophages by modulating CFTR dependent lipid-raftsA Putative ABC Transporter Permease Is Necessary for Resistance to Acidified Nitrite and EDTA in Pseudomonas aeruginosa under Aerobic and Anaerobic Planktonic and Biofilm Conditions.Dynamics of mutator and antibiotic-resistant populations in a pharmacokinetic/pharmacodynamic model of Pseudomonas aeruginosa biofilm treatment.A clonal group of nontypeable Haemophilus influenzae with two IgA proteases is adapted to infection in chronic obstructive pulmonary disease.Bronchial microbiome of severe COPD patients colonised by Pseudomonas aeruginosaEvolutionary adaptations of biofilms infecting cystic fibrosis lungs promote mechanical toughness by adjusting polysaccharide production.Pathogenicity islands PAPI-1 and PAPI-2 contribute individually and synergistically to the virulence of Pseudomonas aeruginosa strain PA14Aspergillus colonization in patients with chronic obstructive pulmonary diseasePseudomonas aeruginosa isolates in severe chronic obstructive pulmonary disease: characterization and risk factors.Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease.Pseudomonas aeruginosa elastase provides an escape from phagocytosis by degrading the pulmonary surfactant protein-A.Cell wall stress activates expression of a novel stress response facilitator (SrfA) under σ22 (AlgT/U) control in Pseudomonas aeruginosa.Critical modifier role of membrane-cystic fibrosis transmembrane conductance regulator-dependent ceramide signaling in lung injury and emphysema.Antibiotics against Pseudomonas aeruginosa for COPD exacerbation in ICU: a 10-year retrospective studyManagement of patients during and after exacerbations of chronic obstructive pulmonary disease: the role of primary care physicians.Inhibiting an Epoxide Hydrolase Virulence Factor from Pseudomonas aeruginosa Protects CFTR.Sputum Bacterial and Fungal Dynamics during Exacerbations of Severe COPDQuantitative analysis of pathogens in the lower respiratory tract of patients with chronic obstructive pulmonary diseaseOsteopontin That Is Elevated in the Airways during COPD Impairs the Antibacterial Activity of Common Innate Antibiotics.The emerging relationship between the airway microbiota and chronic respiratory disease: clinical implicationsPseudomonas aeruginosa quorum sensing molecules correlate with clinical status in cystic fibrosisBronchial microbiome, PA biofilm-forming capacity and exacerbation in severe COPD patients colonized by P. aeruginosa.Microenvironmental characteristics and physiology of biofilms in chronic infections of CF patients are strongly affected by the host immune response.Visualizing the Mechanism of Epoxide Hydrolysis by the Bacterial Virulence Enzyme Cif.Airway epithelial expression of TLR5 is downregulated in healthy smokers and smokers with chronic obstructive pulmonary diseaseNKG2D is critical for NK cell activation in host defense against Pseudomonas aeruginosa respiratory infection.Targeting Nrf2 signaling improves bacterial clearance by alveolar macrophages in patients with COPD and in a mouse modelLung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation.Pyocyanin-induced mucin production is associated with redox modification of FOXA2.Iron-Depletion prevents biofilm formation in Pseudomonas Aeruginosa through twitching mobility and quorum sensing.Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations.Efficacy of aerosol MP-376, a levofloxacin inhalation solution, in models of mouse lung infection due to Pseudomonas aeruginosa.Evaluation effects of nebulized gentamicin in exacerbation of chronic obstructive lung disease.
P2860
Q22305860-233D0A76-309E-4F09-842D-5F5DDB6A04BEQ24629214-9F69E2E2-9042-4DA8-8E5E-DE6DD3FE07B7Q26996706-3BDC0E5A-0368-435F-83C7-8BDF4E1B67BAQ27327282-EE3733CD-1405-48E8-85D0-E79E527614D0Q27687411-506CC47A-F56A-4A1A-9CCA-D444643DBCA8Q28071694-59E9AC68-BAFC-4BBA-A50F-39CDCB1B2570Q28393450-DFFF1106-48F2-42FF-A390-EB0D4082F65AQ28544815-DAAA61A9-ACFB-4BCA-8A25-53420AC3E901Q29346826-323B64E1-80A6-4962-9540-C6D51542A7E3Q31029779-10273C06-F9BE-4236-9F13-306467900BA2Q31037676-7FBBE3D3-BF1C-4D0E-BCEF-C4B03DCE42ADQ33701145-C5A5C80C-188F-4889-83C0-5FF92F1BFF92Q33731316-0D9B8CD9-2E9B-42B4-9A6E-AEC1D687941EQ33769060-426A4ACE-957D-4FC9-AF79-8B15A2A4624AQ33851401-AA721C39-A358-4307-9BC9-DA4259C0B772Q33889496-CB5B228C-83A5-452A-98A5-3FEC756FEA0FQ34058686-1CFD3E9E-A655-4564-80C6-6B4E9EFE15E2Q34070575-8C266884-69C6-4FCC-8AAA-CFA8C2931679Q34762383-39CDF374-71D9-4969-B99F-F58D5D2F865AQ35059259-F325AA25-EA09-47F3-BCF4-F06899154328Q35110953-CDF5BA72-BCC1-4ECA-AF03-C4F817EC8B08Q35225129-ECE6F5A9-0065-4BAB-9EF2-4703C37D75B5Q35681388-CFA8E9BE-C241-4EE6-AF9E-A37C6817E108Q35683454-EFB33BAB-CBAE-4610-AE8C-C79010DFA63DQ35749457-FEC09908-343F-4761-80C3-D7507619FDB3Q35885852-DB7A0A48-5573-409C-8DAC-17ED2536496DQ35987288-1AFAEB3D-DCAA-423F-996E-D0765951FBA0Q36108849-11575E3C-7F47-4533-9334-AEEC7753D81DQ36321964-E9F8960F-456E-49CA-AF8B-3CC1A5535C48Q36346231-91514BDE-38C1-4F53-8048-905C9ADCABA4Q36614104-A0C6EA65-D69F-44F3-B5B3-4B466F03429EQ36630709-0FDA5AF9-15E2-4E6E-A4AD-2FB392448A8FQ36935922-01FDDA15-7B92-49BB-9387-0AB16ED70E9CQ37054081-EC2CC517-EBC0-4383-8C55-D45223B9D9AAQ37072994-A7CF2F92-8A17-41AD-BC6D-FFAB3AE0C685Q37153057-E2813734-4E0E-4660-B659-70C82834A920Q37159428-A147A931-2C40-4F36-9154-B47050B915BBQ37177278-03AD25AA-081F-4099-A14D-42E5A2DA2A42Q37333121-55CC0B4E-1473-4A79-B683-3775D823528AQ37436736-364C5DD3-8B4A-4F1C-8C21-BEABFF53808D
P2860
Pseudomonas aeruginosa in chronic obstructive pulmonary disease.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Pseudomonas aeruginosa in chronic obstructive pulmonary disease.
@en
Pseudomonas aeruginosa in chronic obstructive pulmonary disease.
@nl
type
label
Pseudomonas aeruginosa in chronic obstructive pulmonary disease.
@en
Pseudomonas aeruginosa in chronic obstructive pulmonary disease.
@nl
prefLabel
Pseudomonas aeruginosa in chronic obstructive pulmonary disease.
@en
Pseudomonas aeruginosa in chronic obstructive pulmonary disease.
@nl
P2093
P2860
P1476
Pseudomonas aeruginosa in chronic obstructive pulmonary disease.
@en
P2093
Aimee L Brauer
Karen Eschberger
Lori Grove
Phyllis Lobbins
Sanjay Sethi
P2860
P304
P356
10.1164/RCCM.200709-1413OC
P407
P577
2008-01-17T00:00:00Z